Nature1 month agoOMG scienceDebate rages over Alzheimer's drug lecanemab as UK limits approvalThe debate over lecanemab centers on balancing its potential cognitive benefits against the risks and costs involved. [ more ]
www.npr.org2 months agoUS newsMammograms have pros and cons for people in their 40s. Women can handle the nuanceEducating women in their 40s on pros and cons of mammograms leads to more informed decisions about screening age. [ more ]